Sunshine Biopharma IncNASDAQ:SBFMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE3.3200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 3.3200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SBFM |
|---|---|---|
| 09:32 ET | 171543 | 2.28 |
| 09:34 ET | 43563 | 2.335 |
| 09:36 ET | 50781 | 2.3899 |
| 09:38 ET | 128211 | 2.32 |
| 09:39 ET | 215975 | 2.1913 |
| 09:41 ET | 364470 | 2.02 |
| 09:43 ET | 227667 | 1.975 |
| 09:45 ET | 93632 | 2.045 |
| 09:48 ET | 79426 | 2.08 |
| 09:50 ET | 73804 | 2.1099 |
| 09:52 ET | 69287 | 2.055 |
| 09:54 ET | 56154 | 2.0775 |
| 09:56 ET | 52220 | 2.0701 |
| 09:57 ET | 139359 | 2.135 |
| 09:59 ET | 48977 | 2.135 |
| 10:01 ET | 70196 | 2.14 |
| 10:03 ET | 43237 | 2.175 |
| 10:06 ET | 74994 | 2.19 |
| 10:08 ET | 123104 | 2.17 |
| 10:10 ET | 30698 | 2.1399 |
| 10:12 ET | 49638 | 2.0999 |
| 10:14 ET | 11210 | 2.1008 |
| 10:15 ET | 52704 | 2.0852 |
| 10:17 ET | 16565 | 2.0801 |
| 10:19 ET | 23732 | 2.1192 |
| 10:21 ET | 19965 | 2.11 |
| 10:24 ET | 35777 | 2.0899 |
| 10:26 ET | 28426 | 2.1099 |
| 10:28 ET | 23381 | 2.13 |
| 10:30 ET | 19808 | 2.14 |
| 10:32 ET | 24825 | 2.12 |
| 10:33 ET | 14730 | 2.129 |
| 10:35 ET | 33399 | 2.1417 |
| 10:37 ET | 41407 | 2.135 |
| 10:39 ET | 56177 | 2.1601 |
| 10:42 ET | 44736 | 2.1485 |
| 10:44 ET | 5075 | 2.1309 |
| 10:46 ET | 16177 | 2.12 |
| 10:48 ET | 21774 | 2.11 |
| 10:50 ET | 46212 | 2.1274 |
| 10:51 ET | 27990 | 2.12 |
| 10:53 ET | 8996 | 2.1197 |
| 10:55 ET | 15934 | 2.1188 |
| 10:57 ET | 21948 | 2.1101 |
| 11:00 ET | 16176 | 2.1133 |
| 11:02 ET | 12093 | 2.11 |
| 11:04 ET | 69195 | 2.045 |
| 11:06 ET | 194391 | 2.01 |
| 11:08 ET | 69381 | 2.01 |
| 11:09 ET | 17516 | 1.9907 |
| 11:11 ET | 49153 | 2.0293 |
| 11:13 ET | 40148 | 2.07 |
| 11:15 ET | 29929 | 2.07 |
| 11:18 ET | 15632 | 2.0407 |
| 11:20 ET | 16364 | 2.0594 |
| 11:22 ET | 13453 | 2.0699 |
| 11:24 ET | 22621 | 2.06 |
| 11:26 ET | 41694 | 2.065 |
| 11:27 ET | 92145 | 2.07 |
| 11:29 ET | 10974 | 2.065 |
| 11:31 ET | 14059 | 2.055 |
| 11:33 ET | 26200 | 2.035 |
| 11:36 ET | 12254 | 2.0499 |
| 11:38 ET | 17428 | 2.025 |
| 11:40 ET | 34959 | 2.0012 |
| 11:42 ET | 30752 | 2.0072 |
| 11:44 ET | 57527 | 1.9981 |
| 11:45 ET | 30758 | 2 |
| 11:47 ET | 53970 | 2.015 |
| 11:49 ET | 40838 | 2.005 |
| 11:51 ET | 15003 | 2.005 |
| 11:54 ET | 20073 | 2.0093 |
| 11:56 ET | 18321 | 2.005 |
| 11:58 ET | 20287 | 2.015 |
| 12:00 ET | 40719 | 2.065 |
| 12:02 ET | 10656 | 2.04 |
| 12:03 ET | 10280 | 2.055 |
| 12:05 ET | 10388 | 2.035 |
| 12:07 ET | 6952 | 2.01 |
| 12:09 ET | 18957 | 2.03 |
| 12:12 ET | 12121 | 2.01 |
| 12:14 ET | 12166 | 2.025 |
| 12:16 ET | 7198 | 2.01 |
| 12:18 ET | 15818 | 2.0207 |
| 12:20 ET | 5879 | 2.025 |
| 12:21 ET | 2085 | 2.0293 |
| 12:23 ET | 5025 | 2.025 |
| 12:25 ET | 30194 | 2.0406 |
| 12:27 ET | 6027 | 2.05 |
| 12:30 ET | 5356 | 2.0399 |
| 12:32 ET | 4842 | 2.0252 |
| 12:34 ET | 4553 | 2.025 |
| 12:36 ET | 10853 | 2.0207 |
| 12:38 ET | 8036 | 2.0272 |
| 12:39 ET | 24033 | 2.02 |
| 12:41 ET | 6950 | 2.0207 |
| 12:43 ET | 2239 | 2.02 |
| 12:45 ET | 11586 | 2.0188 |
| 12:48 ET | 68398 | 1.975 |
| 12:50 ET | 48370 | 1.9797 |
| 12:52 ET | 247814 | 1.8013 |
| 12:54 ET | 115054 | 1.8618 |
| 12:56 ET | 32296 | 1.9 |
| 12:57 ET | 46652 | 1.875 |
| 12:59 ET | 30656 | 1.8487 |
| 01:01 ET | 24195 | 1.8407 |
| 01:03 ET | 16957 | 1.87 |
| 01:06 ET | 14747 | 1.86 |
| 01:08 ET | 13755 | 1.88 |
| 01:10 ET | 13657 | 1.88 |
| 01:12 ET | 17460 | 1.8501 |
| 01:14 ET | 14429 | 1.8699 |
| 01:15 ET | 9815 | 1.86 |
| 01:17 ET | 10009 | 1.8501 |
| 01:19 ET | 14688 | 1.85 |
| 01:21 ET | 7539 | 1.86 |
| 01:24 ET | 46011 | 1.8399 |
| 01:26 ET | 21977 | 1.8216 |
| 01:28 ET | 7966 | 1.8399 |
| 01:30 ET | 9285 | 1.85 |
| 01:32 ET | 28327 | 1.86 |
| 01:33 ET | 17865 | 1.9 |
| 01:35 ET | 23759 | 1.88 |
| 01:37 ET | 6812 | 1.885 |
| 01:39 ET | 11544 | 1.8898 |
| 01:42 ET | 24843 | 1.8611 |
| 01:44 ET | 11104 | 1.8599 |
| 01:46 ET | 27332 | 1.845 |
| 01:48 ET | 10034 | 1.86 |
| 01:50 ET | 16619 | 1.855 |
| 01:51 ET | 16659 | 1.87 |
| 01:53 ET | 16117 | 1.87 |
| 01:55 ET | 9055 | 1.86 |
| 01:57 ET | 18811 | 1.86 |
| 02:00 ET | 13715 | 1.86 |
| 02:02 ET | 9022 | 1.8609 |
| 02:04 ET | 5120 | 1.8588 |
| 02:06 ET | 7356 | 1.86 |
| 02:08 ET | 37938 | 1.8401 |
| 02:09 ET | 17126 | 1.859 |
| 02:11 ET | 14504 | 1.86 |
| 02:13 ET | 9872 | 1.855 |
| 02:15 ET | 11768 | 1.8501 |
| 02:18 ET | 3653 | 1.83 |
| 02:20 ET | 5476 | 1.835 |
| 02:22 ET | 28667 | 1.834 |
| 02:24 ET | 14008 | 1.82 |
| 02:26 ET | 6866 | 1.8303 |
| 02:27 ET | 3681 | 1.825 |
| 02:29 ET | 15321 | 1.839 |
| 02:31 ET | 21661 | 1.83 |
| 02:33 ET | 3800 | 1.825 |
| 02:36 ET | 69584 | 1.805 |
| 02:38 ET | 99261 | 1.76 |
| 02:40 ET | 47700 | 1.766 |
| 02:42 ET | 35976 | 1.76 |
| 02:44 ET | 40435 | 1.82 |
| 02:45 ET | 30107 | 1.825 |
| 02:47 ET | 13762 | 1.81 |
| 02:49 ET | 20095 | 1.81 |
| 02:51 ET | 15738 | 1.8098 |
| 02:54 ET | 10486 | 1.8101 |
| 02:56 ET | 18927 | 1.8393 |
| 02:58 ET | 40287 | 1.84 |
| 03:00 ET | 30556 | 1.8692 |
| 03:02 ET | 34724 | 1.8991 |
| 03:03 ET | 38852 | 1.88 |
| 03:05 ET | 28294 | 1.86 |
| 03:07 ET | 13007 | 1.87 |
| 03:09 ET | 8248 | 1.88 |
| 03:12 ET | 22822 | 1.87 |
| 03:14 ET | 72794 | 1.8594 |
| 03:16 ET | 11780 | 1.85 |
| 03:18 ET | 11816 | 1.825 |
| 03:20 ET | 79631 | 1.8199 |
| 03:21 ET | 35889 | 1.835 |
| 03:23 ET | 22383 | 1.855 |
| 03:25 ET | 16365 | 1.85 |
| 03:27 ET | 14075 | 1.855 |
| 03:30 ET | 5178 | 1.85 |
| 03:32 ET | 14224 | 1.835 |
| 03:34 ET | 2783 | 1.835 |
| 03:36 ET | 11391 | 1.85 |
| 03:38 ET | 5177 | 1.845 |
| 03:39 ET | 20750 | 1.8224 |
| 03:41 ET | 19333 | 1.8199 |
| 03:43 ET | 10331 | 1.8148 |
| 03:45 ET | 13726 | 1.805 |
| 03:48 ET | 16297 | 1.8 |
| 03:50 ET | 21378 | 1.805 |
| 03:52 ET | 19972 | 1.805 |
| 03:54 ET | 110332 | 1.785 |
| 03:56 ET | 60752 | 1.7558 |
| 03:57 ET | 111834 | 1.765 |
| 03:59 ET | 130348 | 3.32 |
Yesterday
Apr 12, 2024
Sunshine Biopharma Announces Reverse Stock Split, from 9:02AM ET on Friday Apr 12, 2024 by Dow Jones
9:02AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 1, 2024
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023, from 8:02AM ET on Monday Apr 01, 2024 by Dow Jones
8:02AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sunshine Biopharma Inc | 3.3M | -0.2x | --- |
cbdMD Inc | 3.0M | 0.0x | --- |
Cyanotech Corp | 2.3M | -0.5x | --- |
Gelesis Holdings Inc | 1.5M | 0.0x | --- |
Synovics Pharmaceuticals Inc | 3.0K | 0.0x | --- |
Neurobiological Technologies Inc | 30.0 | 0.0x | --- |
Company Information
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a small chemotherapy molecule targeting pancreatic cancer. The K1.1 mRNA is developed for liver cancer. SBFM-PL4 is an anti-coronavirus compound. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio consisting of 50 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.
Contact Information
- Headquarters
- 6500 TRANS-CANADA HIGHWAY, 4TH FLOORPOINTE-CLAIRE, QC, Canada H9R 0A5
- Phone
- 514-426-6161
- Fax
- 514-426-6101
Executives
- Chairman of the Board, President, Chief Executive Officer
- Steve Slilaty
- Chief Financial Officer, Secretary
- Camille Sebaaly
- Chief Operating Officer
- Marc Beaudoin
- Chief Science Officer, Director
- Abderrazzak Merzouki
- Chief Development Officer
- Malek Chamoun
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3M |
|---|---|
Revenue (TTM) | $24.1M |
Shares Outstanding | 994.5K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.89 |
EPS | $-19.07 |
Book Value | $75.68 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -19.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
